Klappentext

Quick and comprehensive information on psychotropic drugs for children and adolescents.
Accurate and up-to-date
Specific to children and adolescents
Charts and tables help decision-making
Icons and full color
More about this book
The Clinical Handbook of Psychotropic Drugs for Children and Adolescents has become a standard reference and working tool for psychiatrists, pediatricians, psychologists, physicians, pharmacists, nurses, and other mental health professionals.
Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions...) for a quick overview of treatment options
Succinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, nursing implications, and much more - all you need to know for each class of drug
Potential interactions and side effects summarized in comparison charts
With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
Clearly written patient and caregiver information sheets for download as printable PDF files
This book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.
New in this edition:
Drugs for ADHD thoroughly revised and updated
Antipsychotics with many changes and additions, including fully revised lab tests / monitoring
Antidepressants fully revised, including new sections on irreversible MAO-B inhibitor and serotonin modulator and stimulator (SMS), revised frequency of adverse effects table and switching strategies recommendations
Hypnotics completely revised
Mood stabilizers fully revised and a new toxicity comparison table added
Drugs of abuse and treatment of substance use disorders comprehensively revised
New unapproved treatments with significant updates, including: anti-inflammatories and NMDA agents in anxiety / OCD, cannabis use disorder, and irritability of autism
New agents include: Third generation antipsychotics brexpiprazole and cariprazine, orexin receptor antagonist suvorexant, selective melatonin agonist tasimelteon, serotonin modulator and stimulator vortioxetine
New formulations and trade names include: Adasuve, Alprazolam Intensol, Aptensio XR, Aristada, Belbuca, Belsomra, Brintellix, Bunavail, Cotempla XR-ODT, Dyanavel XR, Eldepryl, EMSAM, Evekeo, Hemangeol, Hetlioz, Innopran XL, Invega Trinza, Khedezla, Metadol-D, Mydayis, NyQuil, Quillichew ER, Quillivant XR, Rexulti, Tegretol (liquid), Trintellix, Versacloz, Vraylar, Zelapar, Zenzedi
Available products of the Clinical Handbook of Psychotropic Drugs